Clinical Trials · NCT00751790
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Debiopharm International SA
- Enrollment
- 120
- Start date
- Jul 2006
- Locations
- 1 site, South Africa
- Primary endpoint
- Achievement of Castration and Maintenance of Castration